Analysis Tools|
Allele Symbol Allele Name Allele ID |
Tg(CD2-Mir181d)38Oers transgene insertion 38, Nicolai S C van Oers MGI:5588400 |
||||||||||||
| Summary |
2 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• dramatic reduction in the periphery
|
|
• dramatic reduction in the periphery
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• mice exhibit normal proportion and numbers of gamma-delta T cell and NK1.1 cells
• the rate of cell death of double positive thymocytes is normal
• peripheral B220+ B cell percentages are normal
• T cell function after egress from the thymus is normal
|
|
• augmented stress-induced thymic atrophy using dexamethasone
|
|
• slightly in the periphery
|
|
• percent and number in untreated mice
• in LPS- or dexamethasone-treated mice
|
|
• reduced percentage and numbers of mature CD4-CD8+ T cells in lymph nodes and spleen
|
|
• augmented stress-induced thymic atrophy using dexamethasone
|
|
• augmented stress-induced thymic atrophy using dexamethasone
|
|
• slightly in the periphery
|
|
• percent and number in untreated mice
• in LPS- or dexamethasone-treated mice
|
|
• reduced percentage and numbers of mature CD4-CD8+ T cells in lymph nodes and spleen
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 12/30/2025 MGI 6.24 |
|
|
|
||
